Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Ultralife (ULBI) Free Cash Flow (2016 - 2025)

Ultralife has reported Free Cash Flow over the past 16 years, most recently at $4.1 million for Q4 2025.

Quarterly results put Free Cash Flow at $4.1 million for Q4 2025, down 1.67% from a year ago — trailing twelve months through Dec 2025 was $10.6 million (down 35.53% YoY), and the annual figure for FY2025 was $10.6 million, down 35.53%.
Free Cash Flow for Q4 2025 was $4.1 million at Ultralife, up from -$797000.0 in the prior quarter.
Over the last five years, Free Cash Flow for ULBI hit a ceiling of $8.6 million in Q2 2024 and a floor of -$4.6 million in Q4 2021.
Median Free Cash Flow over the past 5 years was $1.4 million (2023), compared with a mean of $1.4 million.
Biggest five-year swings in Free Cash Flow: crashed 377.01% in 2021 and later surged 645.92% in 2025.
Ultralife's Free Cash Flow stood at -$4.6 million in 2021, then increased by 22.35% to -$3.6 million in 2022, then skyrocketed by 139.72% to $1.4 million in 2023, then soared by 189.0% to $4.1 million in 2024, then decreased by 1.67% to $4.1 million in 2025.
The last three reported values for Free Cash Flow were $4.1 million (Q4 2025), -$797000.0 (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.